Drug Pricing: Public Disclosure of Government Deals
A house committee must act next: committee consideration.
This is a partisan bill introduced by Democrats that specifically targets the current administration's private negotiations, making it unlikely to gain support from the majority party.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
The required CBO and GAO report must analyze how these drug pricing deals affect qualified health plans sold on ACA marketplaces, giving marketplace enrollees data on whether the deals raised or lowered their costs. No marketplace rules or subsidies change under this bill.
“qualified health plans offered through the American Health Benefit Exchanges established under section 1311 or 1321 of the Patient Protection and Affordable Care Act ( 42 U.S.C. 18031 ; 18041)”
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
House Democrats introduced the Drug Deal Disclosure Act on July 15, 2026. The bill would require HHS to release all records and contracts related to private drug pricing deals made since January 2025, targeting agreements with major companies like Pfizer and Eli Lilly.
President Trump announced an expansion of the TrumpRx platform to include 600 generic medications. While the administration touts the platform's transparency, critics in Congress are calling for the full disclosure of the underlying contracts through the Drug Deal Disclosure Act.
No votes or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Drug Deal Disclosure Act
Analysis generated by AI. Always verify with official sources.